: Symptom Management Allgorythm for Chronic Kidney Disease
Renal Palliative Care Initiative: Symptom Management Allgorythm for Chronic
This is a chart of commonly occurring symptoms experienced by patients of end
stage renal disease, and recommended treatments.
Clinical Care Tools - Symptom Management
Renal Palliative Care Initiative
Baystate Medical Center
759 Chestnut Street S2669
Springfield, MA 01199
Michael Germain, M.D.
How the grantee used this instrument:
This chart was made available at the clinics and renal unit nursing stations.
esrd, end stage renal disease, dialysis, kidney disease, symptom assessment
To use this tool:
You may print and copy this tool for your own use from this site. Please credit
- Ponticelli, C., Bencini, P.L., "Uremic Pruritis: A Review Nephron" 1992;60:1-5
A.O., et al, "Efficacy of Quinine Versus Vitamin E" American
Society for Artificial Internal Organs Journal, 1992; 38: M481-M485
- Lin, S et al, "Effect of Pramipexole in Treatment of Resistant
Restless Legs Syndrome." Mayo Clinic Proc 1998 73:497-500
- Ponticelli, C.,
Bencini, P.L., Uremic Pruritis: A Review Nephron 1992;60:1-5
- Morton, C.,
Lafferty, M., Hau, C., Henderson, I., Jones, M. & Lowe,
J. (1996). "Pruritis and skin hydration during dialysis." Nephrology,
Dialysis, Transplantation, 11, 2031 2036.
- Giovanetti, S., Barsotti, G., Cupisti,
A. (1995). "Oral activated charcoal in patients with uremic pruritus." Nephron,
- Schultz, B. & Roenigk, K. (1980). "Uremic pruritus treated
light." Journal of the American Medical Association
- Tapia, L, Cheigh, H., David, D. (1977). "Pruritus in dialysis patients
treated with parenteral lidocaine." New England Journal of Medicine, 296,
- Francos, G., Kauh, V.,Grittlen, S. (1991). "Elevated plasma
histamine in chronic uremia effects of ketotifen on pruritus." International
of Dermatology, 30. 884-889.
- Silva S. et al, "Thalidomide for the Treatment
of Uremic Pruritis: A Crossover Randomized Double-Blind Trial," Nephron,
C.E.H., et al, "Plasmapheresis for Severe, Unremitting, Chronic Uticaria."
- Balaskas, E., Bamihas, G., Karamouzis, M.,
Voyiatzis, G. & Tourkantonis,
A. (1998). "Histamine and serotonin in uremic pruritus: effect of ondansetron
in CAPD-pruritic patients." Nephron, 78, 395-402
- Peer, G., Kivity, s.,
Agami, O., Fireman, E., Silverberg, D., Blum, M. & Ianina, A. (1996).
"Randomized crossover trial of naltrexone in uraemic pruritus." Lancet, 348,
- Grattan, C.E.H., et al, "Plasmapheresis for Severe, Unremitting,
Chronic Uticaria." Lancet,1992;339:1078-1080
- Bonomini, V., Coli, L.,
Scolari, M.P. "Profiling Dialysis: A New Approach To Dialysis Intolerance
" Nephron, 1997;75:1-6
- Fang, J, Huang, C. "Midodrine in Patients on Hemodialysis
with Chronic Hypotension Renal Failure," 1996;18:253-260
- Dheenan, S.
et al, "Effects of Sertraline on Dialysis Hypotension." American
Journal of Kidney Disease, 1998;31:624-630
J.A. et al (2000). "The effects of megestrol acetate on nutritional parameters
in a dialysis population." Journal of
To view this tool:
Left click on the download link to view the PDF document in your Web browser.
Right-click on the download link to save the document to your computer.
135 KB / 3 pages (Viewing PDF files requires downloading
and installation of the free Adobe
Posted April 2004
Baystate Medical Center overview page
# BMC17, type:symptom_management
Promoting Excellence in End-of-Life Care was a national program of the Robert Wood Johnson Foundation dedicated to long-term changes in health care institutions to substantially improve care for dying people and their families. Visit PromotingExcellence.org for more resources.